As of 2024-09-20, the Relative Valuation of Edwards Lifesciences Corp (EW) is 91.46 USD. This relative valuation is based on P/E multiples. With the latest stock price at 66.83 USD, the upside of Edwards Lifesciences Corp based on Relative Valuation is 36.9%.
The range of the Relative Valuation is 76.49 - 104.51 USD.
| Range | Selected | |
| Trailing P/E multiples | 39.3x - 42.7x | 42.2x |
| Forward P/E multiples | 31.3x - 34.8x | 32.7x |
| Fair Price | 76.49 - 104.51 | 91.46 |
| Upside | 14.4% - 56.4% | 36.9% |
| Date | P/E |
| 2024-09-20 | 27.33 |
| 2024-09-19 | 27.51 |
| 2024-09-18 | 27.62 |
| 2024-09-17 | 27.49 |
| 2024-09-16 | 28.37 |
| 2024-09-13 | 28.02 |
| 2024-09-12 | 27.86 |
| 2024-09-11 | 27.91 |
| 2024-09-10 | 27.46 |
| 2024-09-09 | 26.87 |
| 2024-09-06 | 27.32 |
| 2024-09-05 | 27.00 |
| 2024-09-04 | 28.19 |
| 2024-09-03 | 28.12 |
| 2024-08-30 | 28.61 |
| 2024-08-29 | 28.68 |
| 2024-08-28 | 28.08 |
| 2024-08-27 | 28.48 |
| 2024-08-26 | 28.12 |
| 2024-08-23 | 28.99 |
| 2024-08-22 | 29.16 |
| 2024-08-21 | 28.66 |
| 2024-08-20 | 28.37 |
| 2024-08-19 | 27.92 |
| 2024-08-16 | 28.19 |
| 2024-08-15 | 27.86 |
| 2024-08-14 | 27.20 |
| 2024-08-13 | 27.13 |
| 2024-08-12 | 26.80 |
| 2024-08-09 | 26.44 |
| 2024-08-08 | 25.88 |
| 2024-08-07 | 24.98 |
| 2024-08-06 | 25.36 |
| 2024-08-05 | 24.82 |
| 2024-08-02 | 24.88 |
| 2024-08-01 | 25.30 |
| 2024-07-31 | 25.79 |
| 2024-07-30 | 26.03 |
| 2024-07-29 | 26.07 |
| 2024-07-26 | 25.51 |
| 2024-07-25 | 24.41 |
| 2024-07-24 | 35.56 |
| 2024-07-23 | 35.60 |
| 2024-07-22 | 35.98 |
| 2024-07-19 | 35.38 |
| 2024-07-18 | 35.09 |
| 2024-07-17 | 35.71 |
| 2024-07-16 | 35.88 |
| 2024-07-15 | 36.60 |
| 2024-07-12 | 37.21 |